Company · Toronto, Ontario, Canada
Bdh Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 36
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 23
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ACETATE CONCENTRATE R07318 LIQ | 00898287 | Cancelled Post Market | |
| ACETATE CONCENTRATE R07376 | 02179075 | Cancelled Post Market | |
| ACID CONCENTRATE RX252C | 02179148 | Cancelled Post Market | |
| ACID CONCENTRATE RX253C | 02179156 | Cancelled Post Market | |
| ACID CONCENTRATE(36.83X) R04900 | 00661155 | Cancelled Post Market | |
| ACID CONCENTRATE(36.83X) R04906 | 00661147 | Cancelled Post Market | |
| ACID CONCENTRATE-R04948 LIQ | 00897809 | Cancelled Post Market | |
| AZATHIOPRINE | 02235352 | Cancelled Post Market | |
| BACLOFEN TABLETS - 10MG | 02147556 | Cancelled Post Market | |
| BACLOFEN TABLETS - 20MG | 02147564 | Cancelled Post Market | |
| CYPROTERONE | 02237253 | Cancelled Post Market | |
| ETOPOSIDE - LIQ IV 20MG/ML | 02227509 | Cancelled Post Market | |
| K1 LIQ R04911 | 00897167 | Cancelled Post Market | |
| K1 LIQ R04978 | 00896942 | Cancelled Post Market | |
| K2 LIQ R04902 | 00897124 | Cancelled Post Market | |
| K2 WITH GLUCOSE LIQ R04977 | 00896934 | Cancelled Post Market | |
| LACTULOSE SOLUTION USP - LIQ 667MG/ML | 02148056 | Cancelled Post Market | |
| METFORMIN | 02231389 | Cancelled Post Market | |
| MILK OF MAGNESIA - CASCARA SUSPENSION CONC. | 02142953 | Cancelled Post Market | |
| MILK OF MAGNESIA MINERAL OIL EMULSION | 02142996 | Cancelled Post Market | |
| MILK OF MAGNESIA USP | 02142988 | Cancelled Post Market | |
| MINERAL OIL USP | 02142961 | Cancelled Post Market | |
| R04903 LIQ | 00869554 | Cancelled Post Market | |
| R04909 LIQ | 00869562 | Cancelled Post Market | |
| R04919 LIQ | 00869570 | Cancelled Post Market | |
| R04922 LIQ | 00869589 | Cancelled Post Market | |
| R04931 LIQ | 00869597 | Cancelled Post Market | |
| R04936 LIQ | 00869619 | Cancelled Post Market | |
| R04940 LIQ | 00869627 | Cancelled Post Market | |
| R04945 LIQ | 00869651 | Cancelled Post Market | |
| R04946 LIQ | 00869678 | Cancelled Post Market | |
| R04972 LIQ | 00869716 | Cancelled Post Market | |
| R04973 LIQ | 00869724 | Cancelled Post Market | |
| SALBUTAMOL INHALATION SOLUTION P.F.-1MG/ML | 02148617 | Cancelled Post Market | |
| TIMOLOL SOLUTION - 0.25% | 02147475 | Cancelled Post Market | |
| TIMOLOL SOLUTION - 0.5% | 02147483 | Cancelled Post Market |
Notices of Compliance
Newest first.
- BECLOMETHASONE AQFebruary 11, 1998 · NOC 2734 · New Drug Submission (NDS)
- BUSPIRONEFebruary 11, 1998 · NOC 2735 · Abbreviated New Drug Submission (ANDS)
- CYPROTERONEFebruary 11, 1998 · NOC 2806 · Abbreviated New Drug Submission (ANDS)
- AMANTADINEFebruary 5, 1998 · NOC 2700 · New Drug Submission (NDS)
- ATENOLOLFebruary 5, 1998 · NOC 2701 · New Drug Submission (NDS)
- INDAPAMIDEFebruary 5, 1998 · NOC 2995 · New Drug Submission (NDS)
- SALBUTAMOL RESPIRATOR SOLUTIONFebruary 5, 1998 · NOC 3213 · New Drug Submission (NDS)
- SOTALOL TABLETNovember 17, 1997 · NOC 4089 · New Drug Submission (NDS)
- SALBUTAMOL INHALATION SOLUTION P.F. 2 MG/MLNovember 10, 1997 · NOC 4062 · New Drug Submission (NDS)
- SELEGILINENovember 10, 1997 · NOC 4068 · New Drug Submission (NDS)
- VALPROICNovember 10, 1997 · NOC 4109 · New Drug Submission (NDS)
- AZATHIOPRINEOctober 6, 1997 · NOC 3298 · Abbreviated New Drug Submission (ANDS)
- CLONAZEPAMOctober 6, 1997 · NOC 3675 · New Drug Submission (NDS)
- METFORMINMay 29, 1997 · NOC 3941 · New Drug Submission (NDS)
- ETOPOSIDEAugust 6, 1996 · NOC 4392 · New Drug Submission (NDS)
- PANCURONIUMAugust 6, 1996 · NOC 4611 · New Drug Submission (NDS)
- ALPRAZOLAMJanuary 16, 1995 · NOC 4748 · New Drug Submission (NDS)
- BACLOFENJanuary 16, 1995 · NOC 4751 · New Drug Submission (NDS)
- CLOMIPRAMINEJanuary 16, 1995 · NOC 4754 · New Drug Submission (NDS)
- GLYBURIDEJanuary 16, 1995 · NOC 5038 · New Drug Submission (NDS)
- TAMOXIFENJanuary 16, 1995 · NOC 5286 · New Drug Submission (NDS)
- SALBUTAMOL INHALATION SOLUTIONJanuary 12, 1995 · NOC 5256 · New Drug Submission (NDS)
- TIMOLOL OPHTHALMICJanuary 12, 1995 · NOC 5287 · New Drug Submission (NDS)